Chemours Co
For the period ended Mar 31, 2024. Filed Apr 30, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed Apr 30, 2024
CC$13.48+1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Interim Consolidated Statements of Stockholders’ Equity (Unaudited)
| Common Stock · Treasury Stock · Additional Paid-in · Retained · Accumulated Other Comprehensive · Non-controlling | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount · Capital · Earnings · (Loss) Income · Interests · Total Equity | ||||||||||
| Balance at January 1, 2023 | 195,375,810 | $2 | 46,871,780 | $(1,738) | $1,016 | $2,170 | $(343) | $— | $1,107 | |
| Common stock issued - compensation plans | 849,164 | — | — | — | — | — | — | — | — | |
| Exercise of stock options | 140,570 | — | — | — | 2 | — | — | — | 2 | |
| Purchases of treasury stock, at cost | — | — | 386,000 | (13) | — | — | — | — | (13) | |
| Stock-based compensation expense | — | — | — | — | 4 | — | — | — | 4 | |
| Cancellation of unissued stock awards withheld to cover taxes | — | — | — | — | (18) | — | — | — | (18) | |
| Net income | — | — | — | — | — | 145 | — | 1 | 146 | |
| Dividends declared on common shares ($0.25 per share) | — | — | — | — | — | (37) | — | — | (37) | |
| Other comprehensive income | — | — | — | — | — | — | 37 | 37 | ||
| Balance at March 31, 2023 | 196,365,544 | 2 | 47,257,780 | (1,751) | 1,004 | 2,278 | (306) | 1 | $1,228 | |
| Balance at January 1, 2024 | 197,519,784 | $2 | 48,932,387 | $(1,806) | $1,033 | $1,782 | $(274) | $2 | $739 | |
| Common stock issued - compensation plans | 161,325 | — | — | — | — | — | — | — | — | |
| Exercise of stock options | 30,727 | — | — | — | 1 | — | — | — | 1 | |
| Purchases of treasury stock, at cost | — | — | — | — | — | — | — | — | — | |
| Stock-based compensation expense | — | — | — | — | 1 | — | — | — | 1 | |
| Cancellation of unissued stock awards withheld to cover taxes | — | — | — | — | (2) | — | — | — | (2) | |
| Net income | — | — | — | — | — | 52 | — | 52 | ||
| Dividends declared on common shares ($0.25 per share) | — | — | — | — | — | (37) | — | — | (37) | |
| Other comprehensive income | — | — | — | — | — | — | — | — | — | |
| Balance at March 31, 2024 | 197,711,836 | $2 | 48,932,387 | $(1,806) | $1,033 | $1,797 | $(274) | $2 | $754 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.